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Sjögren syndrome (SS) is a chronic autoimmune disease characterized by dryness of the 
mouth and eyes due to lymphocytic infiltration of the exocrine glands. In American Euro-
pean Consensus Group (AECG) criteria, abnormal salivary gland scintigraphy (SGS) result 
is one of the objective signs of SS and it has been proposed as a valid and non-invasive 
alternative approach to functional evaluation of salivary gland, especially in the case when 
unstimulated whole salivary flow is more than 1.5 mL in 15 minutes or other AECG criteria 
is unmet. Patients with SS are more likely to have the thyroid disease (TD), but this associa-
tion remains controversial. We present a case of the use of SGS for diagnosis of primary SS 
and TD in patients with dry mouth and burning sensation of tongue. Through this case, we 
suggest the usefulness of salivary scintigraphy for screening TD in addition to diagnosis of 
SS.
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INTRODUCTION
Sjögren syndrome (SS) is a chronic autoimmune dis-
ease characterized by dryness of the mouth and eyes due 
to lymphocytic infiltration of the exocrine glands [1]. It 
may occur alone as primary Sjögren syndrome (pSS) or 
be associated with other connective tissue diseases as sec-
ondary SS. Although the recent diagnostic criteria for SS 
are American College of Rheumatology/European League 
Against Rheumatism (ACR/EULAR, 2016) criteria American 
European Consensus Group (AECG, 2002) criteria are still 
used in National Health Insurance policy for incurable-
disease. The AECG criteria are widely accepted which are 
based on a positive response to a short questionnaire of 
ocular and oral symptoms, ocular signs, histopathology, 
oral signs including at least one of these 3, unstimulated 
whole gland salivary flow (≤0.1 mL/min), abnormal parotid 
sialography or abnormal salivary gland scintigraphy (SGS), 
and autoantibodies serum. For the diagnosis of pSS, any 4 
of these 6 criteria can be used, provided that histopathology 
or autoantibodies are included or any 3 of the above crite-
ria provided that histopathology, autoantibodies, unstimu-
lated whole salivary flow, SGS or sialography are included 
[2,3]. The result of SGS is one of the objective signs of SS, 
providing a detailed functional evaluation of salivation. It 
measures the amount and speed of radioisotope uptake and 
excretion for all four major salivary glands separately [4]. 
The most common scintigraphic abnormality observed in 
SS, is the impairment of excretion, followed by a decrease 
in tracer accumulation, reflecting glandular parenchyma 
destruction [5]. So it is useful assessment method for pa-
tients who complain of dry mouth although their unstimu-
lated salivary flow rate is more than 0.1 mL/min or other 
AECG criteria is unmet. 
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In this study, we present the case of pSS and thyroid dis-
ease (TD): 58-year-old woman with dry mouth and burning 
sensation of tongue who was diagnosed with pSS, hypothy-
roidism and goiter through SGS.
CASE REPORT
A 58-year-old woman patient had chief complaints of 
dry mouth, burning sensation of tongue, and recurrent oral 
ulcer. The onset of dry mouth and burning pain was about 
2 months ago and oral ulcer was about 3-4 days ago. She 
had been complaining of spontaneous pain on tongue tip 
like burning sensation (VAS 2-3) and it was aggravated by 
fatigue. 
In the first visit, the patient had ulcerative lesion on the 
right lower vestibule area but no oral lesion on the tongue. 
She also complained of dry mouth and dry eyes. On sec-
retary function test (total saliva) salivation was decreased 
slightly as 0.167 mL/min. Laboratory tests including 
complete blood count, routine chemistry, serum iron, total 
iron binding capacity, ferritin, C-reactive protein, erythro-
cyte sedimentation rate (ESR), Vitamin B12, folic acid, fer-
ritin, zinc, thyroid hormones T3 and T4, thyroid stimulat-
ing hormone (TSH), antinuclear antibody, anti-SS-A/Ro 
and anti-SS-B/La were carried out. It revealed that level of 
ESR and TSH was significantly high and free-T4 was sig-
nificantly low. As anti-SS-A/Ro revealed positive indicating 
high possibility of pSS, SGS was done for national health 
insurance benefit diagnosed with pSS in the second visit 
(7 weeks after the first visit). The scintigraphic abnormal-
ity was observed as decrease in tracer accumulation on left 
submandibular gland and bilateral parotid glands. And sig-
nificantly enlarged bilateral thyroid glands with increased 
radiotracer uptake was also observed (Fig. 1). 
In the third visit, she was prescribed pilocarpine, and re-
ferred to endocrinology for thyroid evaluation. In the de-
partment of the endocrinology, sonography was done. And 
it revealed a low suspicious nodule on Left isthmus and 
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Fig. 1. Results of salivary gland scintigraphy. (A) A 5 minute after injection. (B) After stimulation. The images show the accumulation of saliva 
after Tc99m was injected, as well as release of saliva after stimulation. It shows that uptake to the left submandibular and bilateral parotid 
glands is decreased, and Enlarged bilateral thyroid glands with increased radiotracer uptake. ANT, anterior; LT, left; LAT, lateral; RT, right; RSM, 
right submandibular; LSM, left submandibular; RP, right parotid; LP, left parotid.
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several probably benign nodules on both (Fig. 2). She was 
prescribed synthyroxine diagnosed with hypothyroidism 
and goiter by endocrinologist.
In the fourth visit, she didn’t complain of oral pain and 
dry mouth and the unstimulated salivary flow rate became 
normal. In the fifth visit, increased salivary flow rate was 
maintained after stop taking the pilocarpine. 
DISCUSSION
SS is an autoimmune disease that mainly affects the exo-
crine glands and induces functional impairment of salivary 
gland and lacrimal gland presenting as dry mouth and dry 
eyes. It may occur alone as pSS or be associated with other 
connective tissue diseases as secondary SS [6]. 
Thyroid, salivary, and lacrimal glands are similar from a 
histological and functional point of view. This suggests that 
autoimmune TD and SS can be related immunologically 
each other. Although association of TD with SS remains 
controversial, Hashimoto’s thyroiditis with SS was recently 
confirmed [6]. The prevalence of Hashimoto’s thyroiditis in 
SS was higher than in the general population [7]. Patients 
with pSS also have an increased tendency to develop other 
autoimmune disease like autoimmune TD, and the most fre-
quent hormonal profile is subclinical hypothyroidism [8]. 
In regard to the correlation of TD with SS, one-third of pa-
tients with TD may have symptom of xerostomia and ap-
proximately 10% of patients with anti-nuclear antibody 
positive autoimmune thyroiditis fulfill the criteria for the 
diagnosis of SS [9,10]. This suggests that the symptom of 
dry mouth should be considered as possible sign of TD [11].
In addition, the level of anti-TPO, anti-TG, free T3, free 
T4 and TSH indices is associated with burning mouth syn-
drome in patients with Hashimoto’s thyroiditis. Especially 
hypothyroidism is one of the factors affecting burning sen-
sation [12]. Therefore, if patients with burning mouth syn-
drome visit the clinic, clinicians should consider the possi-
bility of TD and check symptoms including dry mouth. 
SGS, as a diagnostic tool in patients with SS, may be 
helpful for screening TD. This mothed is accepted by AECG 
criteria for SS as objective quantitative evaluation of sali-
vary gland function. In time-activity curve from scintigra-
phy results, excretion fraction (EF%) calculated as [maxi-
mum activity – minimum activity / maximum activity] for 
each major salivary gland is important value of function 
assessment. EF% is significantly reduced in patients with 
dry mouth, especially more than moderate lymphocyte in-
filtration of salivary gland tissue in result of minor salivary 
gland biopsy, compared with less than mild lymphocyte in-
filtration [2]. 
The advantages of scintigraphy compared with other 
methods, such as computed tomography, magnetic reso-
nance imaging, sialography and sialometry, are non-inva-
sive, reproducible and easy to perform. Most of all, quanti-
tative assessment of SGS is sensitive enough to detect ex-
cretion abnormalities not only major salivary glands but 
also thyroid glands [5,13]. In the way that AECG criteria are 
still used in National Health Insurance policy for SS, SGS is 
useful for diagnosis. 
In conclusion, SGS is worthy to be considered for diagno-
sis of SS when patients complain of dry mouth. The risk of 
TD in patients with pSS is significantly increased. Therefore, 
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Fig. 2.  Results of thyroid gland sono-
graphy. (A) Right thyroid gland, (B) left 
thyroid gland. Arrowheads indicate 
probably benign nodules on both 
thyroid gland, respectively. It shows 
enlarged bilateral thyroid glands with 
heterogeneous echogenicity.
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SGS can be used for early detection of TD especially to 
women with pSS.
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